New CAR-T therapy aims to control Hard-to-Treat blood cancers

NCT ID NCT07502118

First seen Apr 23, 2026 · Last updated May 14, 2026 · Updated 2 times

Summary

This study tests a new treatment called Talikabtagene autoleucel (a CAR-T cell therapy) for adults with B-cell cancers like leukemia or lymphoma that have come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target cancer cells. The goal is to shrink or control the cancer, but ongoing monitoring is needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA (FL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ankara Bilkent City Hospital - Hematology Clinic

    RECRUITING

    Ankara, Turkey (Türkiye)

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ankara Etlik City Hospital - Hematology Clinic

    RECRUITING

    Ankara, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology

    NOT_YET_RECRUITING

    Ankara, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

    RECRUITING

    Ankara, Turkey (Türkiye)

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.